Deal Anna, Crawshaw Alison F, Salloum Maha, Hayward Sally E, Carter Jessica, Knights Felicity, Seedat Farah, Bouaddi Oumnia, Sanchez-Clemente Nuria, Muzinga Lutumba Laura, Mimi Kitoko Lusau, Nkembi Sarah, Hickey Caroline, Mounier-Jack Sandra, Majeed Azeem, Hargreaves Sally
The Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
The Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Vaccine. 2024 May 10;42(13):3206-3214. doi: 10.1016/j.vaccine.2024.04.005. Epub 2024 Apr 16.
The World Health Organization's (WHO) Immunization Agenda 2030 emphasises ensuring equitable access to vaccination across the life course. This includes placing an emphasis on migrant populations who may have missed key childhood vaccines, doses, and boosters due to disrupted healthcare systems and the migration process, or differing vaccination schedules in home countries. Guidelines exist in the UK for offering catch-up vaccinations to adolscent and adult migrants with incomplete or uncertain vaccination status (including MMR, Td-IPV, MenACWY, HPV), but emerging evidence suggests awareness and implementation in primary care is poor. It is unclear whether patient-level barriers to uptake of catch-up vaccinations also exist. We explored experiences and views around catch-up vaccination among adult migrants from a range of backgrounds, to define strategies for improving catch-up vaccination policy and practice.
In-depth semi-structured interviews were carried out in two phases with adult migrant populations (refugees, asylum seekers, undocumented migrants, those with no recourse to public funds) on views and experiences around vaccination, involving a team of peer researchers from specific migrant communities trained through the study. In Phase 1, we conducted remote interviews with migrants resident in the UK for < 10 years, from diverse backgrounds. In Phase 2, we engaged specifically Congolese and Angolan migrants as part of a community-based participatory study. Topic guides were developed iteratively and piloted. Participants were recruited using purposive, opportunistic and snowball sampling methods. Interviews were conducted in English (interpreters offered), Lingala or French and were audio-recorded, transcribed and analysed using a thematic framework approach in NVivo 12.
71 participants (39 in Phase 1, 32 in Phase 2) were interviewed (Mean age 43.6 [SD:12.4] years, 69% female, mean 9.5 [SD:7] years in the UK). Aside from COVID-19 vaccines, most participants reported never having been offered vaccinations or asked about their vaccination history since arriving in the UK as adults. Few participants mentioned being offered specific catch-up vaccines (e.g. MMR/Td-IPV) when attending a healthcare facility on arrival in the UK. Vaccines such as flu vaccines, pregnancy-related or pre-travel vaccination were more commonly mentioned. In general, participants were not aware of adult catch-up vaccination but regarded it positively when it was explained. A few participants expressed concerns about side-effects, risks/inconveniences associated with access (e.g. links to immigration authorities, travel costs), preference for natural remedies, and hesitancy to engage in further vaccination campaigns due to the intensity of COVID-19 vaccination campaigns. Trust was a major factor in vaccination decisions, with distinctions noted within and between groups; some held a healthcare professional's recommendation in high regard, while others were less trusting towards the healthcare system because of negative experiences of the NHS and past experiences of discrimination, injustice and marginalisation by wider authorities.
The major barrier to adult catch-up vaccination for missed routine immunisations and doses in migrant communities in the UK is the limited opportunities, recommendations or tailored vaccination information presented to migrants by health services. This could be improved with financial incentives for provision of catch-up vaccination in UK primary care, alongside training of healthcare professionals to support catch-up immunisation and raise awareness of existing guidelines. It will also be essential to address root causes of mistrust around vaccination, where it exists among migrants, by working closely with communities to understand their needs and meaningfully involving migrant populations in co-producing tailored information campaigns and culturally relevant interventions to improve coverage.
世界卫生组织(WHO)的《2030年免疫议程》强调要确保在人的一生中公平获得疫苗接种服务。这包括重视移民群体,他们可能由于医疗系统中断和移民过程,或原籍国不同的疫苗接种计划,而错过关键的儿童疫苗、剂量和加强针。英国有针对未完成或疫苗接种状况不确定的青少年和成年移民(包括麻疹、腮腺炎、风疹联合疫苗、破伤风、白喉、灭活脊髓灰质炎疫苗、脑膜炎球菌结合疫苗、人乳头瘤病毒疫苗)提供补种疫苗的指南,但新出现的证据表明,初级保健机构对该指南的认知和执行情况较差。目前尚不清楚在患者层面是否也存在阻碍补种疫苗接种率的因素存在。我们探讨了来自不同背景的成年移民对补种疫苗接种情况经历及看法,以确定改善补种疫苗政策和实践的策略。
对成年移民群体(难民、寻求庇护者、无证移民、没有公共资金求助资格者)进行了两个阶段的深入半结构化访谈,了解他们对疫苗接种的看法和经历,访谈团队包括通过该研究培训的来自特定移民社区的同行研究人员。在第一阶段,我们对居住在英国不满10年、背景各异的移民进行了远程访谈;在第二阶段,作为基于社区的参与性研究的一部分,我们专门与刚果和安哥拉移民进行了交流。主题指南经过反复制定和试点。采用目的抽样、机会抽样和滚雪球抽样方法招募参与者。访谈用英语(提供口译)、林加拉语或法语进行,并进行录音、转录,并在NVivo 12中使用主题框架方法进行分析。
共访谈了71名参与者(第一阶段39名,第二阶段32名)(平均年龄43.6岁[标准差:12.4]岁;69%为女性;在英国平均居住9.5年[标准差:7年])。除了新冠疫苗外,大多数参与者表示,自成年后抵达英国以来,从未有人向他们提供过疫苗接种服务或询问过他们的疫苗接种史。很少有参与者提到在抵达英国时前往医疗机构就诊时,有人向他们提供特定的补种疫苗(如麻疹、腮腺炎、风疹联合疫苗/破伤风、白喉、灭活脊髓灰质炎疫苗)。流感疫苗、与怀孕相关的疫苗或旅行前疫苗等更常被提及。总体而言,参与者并不了解成人补种疫苗,但在得到解释后持积极态度。一些参与者对副作用、接种相关的风险/不便(如与移民当局的联系、交通费用)、对天然疗法的偏好,以及由于新冠疫苗接种活动的强度而对参与进一步的疫苗接种活动犹豫不决表示担忧。信任是疫苗接种决策中的一个主要因素,不同群体内部和群体之间存在差异;一些人非常重视医疗专业人员的建议,而另一些人由于对英国国家医疗服务体系(NHS)的负面经历以及更广泛当局过去的歧视、不公正和边缘化经历,对医疗系统不太信任。
英国移民社区中成年移民错过常规免疫接种和剂量后进行补种疫苗接种的主要障碍是卫生服务机构向移民提供的机会、建议或针对性的疫苗接种信息有限。这可以通过为英国初级保健机构提供补种疫苗接种的经济激励措施来改善,同时培训医疗专业人员以支持补种免疫接种并提高对现有指南的认识。通过与社区密切合作,了解他们的需求,并让移民群体有意义地参与共同制定针对性的宣传活动和与文化相关的干预措施,以提高疫苗接种覆盖率,解决移民中存在的对疫苗接种不信任的根本原因也至关重要。